Liu, J., Zhou, C. (2025). Phase 1 study of LB1410, a bivalent TIM-3/PD-1 bispecific antibody, in patients with advanced solid tumors or lymphoma.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.2586